Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today December 16
February 21, 2022 11:30
Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO® (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma
Merck, a leading science and technology company, today announced the results of an exploratory analysis from the Phase III JAVELIN Bladder 100 trial with 19 additional months of follow-up data from th
February 21, 2022 10:35
Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study[1,2]
Takeda (TSE:4502/NYSE:TAK) today announced the first six-month interim analysis results from INSPIRE, in which clinical remission[*] was observed in 65% of patients in both cohorts who were evaluated
February 18, 2022 16:28
Karen L. Ling joins Galderma’s Advisory Committee
Galderma, the world’s largest independent dermatology company, announced today that Karen L. Ling will join its Advisory Committee, effective March 1, 2022. Karen Ling has a tremendous track record
February 18, 2022 09:10
NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles
NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy. The co
February 17, 2022 15:20
Vifor Pharma reports sustained growth in 2021
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group reported a solid performance in 2021 and an increase in profitability, supported by a strong recovery in Ferinject®
February 17, 2022 11:40
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
Organon (NYSE: OGN) today announced that it has acquired the rights from Bayer AG to Marvelon® and Mercilon®, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, inclu
February 17, 2022 10:21
Capsa Healthcare Announces the Acquisition of Humanscale Healthcare
Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Humanscale Healthcare, a designer and
February 16, 2022 11:46
Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials
Medidata, a Dassault Systèmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for c
February 16, 2022 11:43
BreastScreen Victoria Switches to Rimini Street Support for its Oracle Database Software, Unlocks Resources to Meet Increasing Service Demand
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partn
February 16, 2022 10:03
German Federal Court of Justice Upholds AOP‘s License Rights in Ropeginterferon and PEC’s Liability for Damages.
Since 2017, PharmaEssentia had repeatedly attempted to terminate the agreement with AOP concerning BESREMi® (Ropeginterferon alfa-2b). In October 2020, after two and a half years of arbitral proceedin
February 15, 2022 10:30
Mawi DNA Technologies Awarded Two ISO Certifications
Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management
February 11, 2022 09:00
Vision Care Market is projected to account for over USD 127.73 Bn, in terms of value, by 2028 end: Future Market Insights
The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide. The number of patients with vision-related problems has increased and so is th
February 09, 2022 16:15
Theramex Reinforces its Commitment to Women on International Women’s Day
International Women’s Day is an important date on the calendar to recognise and celebrate the social, economic, culture, political, scientific and many more achievements of women globally. At Theramex
February 09, 2022 13:55
Mandy Moore Partners With Lumenis to Raise Awareness of Dry Eye Disease and OptiLight Treatment
Lumenis today announced that it has partnered with singer-songwriter and actress Mandy Moore as a brand ambassador for OptiLight, a bright solution for dry eyes. Ms. Moore suffered from dry eye diseas
February 08, 2022 15:55
Cook Medical Reproductive Health Business to be Acquired by CooperCompanies
Cook Medical today announced it signed a letter of intent with CooperCompanies to sell the entirety of Cook’s Reproductive Health business within the MedSurg division. CooperCompanies (NYSE:COO), a pu
February 07, 2022 13:50
Takeda Delivers Strong Third Quarter FY2021 Results and Raises Full-Year Forecast Reflecting Strong Momentum
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the third quarter of its fiscal year 2021 (period ended December 31, 2021) driven by robust topline growth of its 14 global br
February 07, 2022 10:30
Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials
Medidata, a Dassault Systèmes company, announced today that Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance pa
February 04, 2022 16:00
Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH
Dr. Reddy‘s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a def
February 03, 2022 17:10
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
Organon (NYSE: OGN), a global women’s health company, is designating International Women’s Day (IWD) on March 8 as a day to recognize the growing health disparities women face that have been exacerbat
February 03, 2022 14:40
Following LSNE Acquisition, PCI Pharma Services Continues to Expand Sterile Fill-Finish Expertise with State-of-the-Art Equipment
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced the addition of three new exceptional automated sterile fill-finish machines in
February 03, 2022 11:30
Third-Party Clinical Study Documents Industry-Leading Long-Term Safety Record and Patient Satisfaction for GC Aesthetics Breast Implants
GC Aesthetics, Ltd. (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets, has announced the results of an independent clini
February 03, 2022 09:35
Vifor Pharma appoints two new members to the Executive Committee
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group today announced the appointment of acting Chief Financial Officer Alexandros Sigalas and Group General Counsel Dr.
February 03, 2022 09:30
Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy
Waters Corporation (NYSE:WAT) today announced it has acquired the technology assets and intellectual property rights of Megadalton Solutions, Inc., an early-stage developer of Charge Detection Mass Sp
February 02, 2022 15:00
Juvenescence Ltd. Portfolio Company Hails Successful Limb Regeneration in Adult Frogs
Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xe
February 02, 2022 13:40
In the 2022 PQE Group Agenda: Boosting Internationalization by Hiring 800 Talents
It has been another successful year for PQE Group, a consulting firm in the LifeScience industry based in Florence (Italy) with 27 offices worldwide. Recently named “Best Managed Company” by Deloitte,
«
57
58
59
60
61
»
25 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
43,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice